Yuyoung Vancomycin Hydrochloride Injection
Vancomycin Hydrochloride 500mg
Injections · Prescription medication
Yuyoung Pharmaceutical Co., Ltd.
MFDS item code 199202573 · Notified 1992.06.13 · Insurance code 648201571
Treatment of intestinal colitis and membranous colitis caused by Staphylococcus and Clostridium difficile infections
This medication is primarily used to treat intestinal colitis caused by Staphylococcus and antibiotic-related membranous colitis caused by Clostridium difficile. It is also effective against infections caused by various strains such as Streptococcus, Staphylococcus, Clostridium difficile, and diphtheroids. When administered as an injection, it is used for endocarditis, osteomyelitis, septic arthritis, peritonitis, meningitis, superficial secondary infections of burn or surgical sites, and it is also used for severe infections such as pneumonia, sepsis, and lung abscesses, particularly when not treatable with penicillin or cephalosporin antibiotics. Oral administration is primarily used for treating intestinal colitis and antibiotic-related membranous colitis. This medication helps treat various infections, aiding in patient recovery.
Capsule: As vancomycin, divide 500mg (potency) per day into doses taken orally for 7-10 days. In severe cases, 2g (potency) per day may be used divided into 3-4 doses, and the total daily dosage should not exceed 2g. Injection: 500mg (potency) administered every 6 hours or 1g (potency) every 12 hours by intravenous infusion. Oral hydrochloride vancomycin is taken at a dose of 500-2000mg per day, divided into 3-4 doses.
Capsule: 40mg (potency) per day per kilogram of body weight, divided into 3-4 doses for 7-10 days, and the total daily dosage should not exceed 2g. Adjust according to age and symptoms. Injection
This medication should not be administered to patients with hypersensitivity to this drug or its components. Caution is advised when administering this medication to patients with hypersensitivity to peptide or aminoglycoside antibiotics or a history of hearing loss. Patients with impaired kidney function require careful monitoring and blood concentration checks as this medication can accumulate in the body. Elderly patients or those with vestibular organ or cochlear damage should also be particularly cautious when using this drug. This medication can rarely cause side effects such as leukopenia, thrombocytopenia, hearing damage, and renal impairment; any unusual symptoms should be reported to medical personnel immediately. Regular hearing tests and kidney function tests are advisable during treatment with this medication. Severe skin reactions or allergic reactions may occur; if symptoms such as skin rashes, itching, or difficulty breathing arise, use should be stopped immediately and treatment sought. To prevent resistance, it is advisable to administer the medication only for the minimum duration needed based on sensitivity testing when used for a prolonged period. Safety during pregnancy is not fully established; therefore, it should only be used during pregnancy when the benefits outweigh the risks, and it is advisable to avoid or discontinue use if breastfeeding. Caution is needed when used in conjunction with other neurotoxic or nephrotoxic drugs as side effects may increase. In cases of overdose, renal function deterioration and hearing damage may occur; immediate medical treatment is required, and special treatment may be needed as this medication is not easily removed through dialysis.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, hypotension, wheezing, anaphylaxis, anaphylactoid symptoms, shock, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), vasculitis, cranial nerve VIII disorders, membranous colitis, jaundice, acute renal failure, hypotension, severe skin abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent contact with air, and it is important to maintain the storage temperature between 1 and 30 degrees Celsius. Proper storage ensures the medication's efficacy and safety.
[Domestic Use] A white to light yellowish-brown freeze-dried powder in a colorless and transparent vial injection [Export Use] A light yellowish-brown powder in a vial injection
10 vials
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Vancomycin Hydrochloride 500mg
Injections · Prescription medication
Yuyoung Pharmaceutical Co., Ltd.
Vancomycin Hydrochloride 500mg
Injections · Prescription medication
HK Innoen Co., Ltd.
Vancomycin Hydrochloride 500mg
Injections · Prescription medication
Aprogen Pharmaceuticals Co., Ltd.
Vancomycin Hydrochloride 500mg
Injections · Prescription medication
Oskorea Pharmaceutical Co., Ltd.
Vancomycin Hydrochloride
Prescription medication
International Pharmaceutical Co., Ltd.
Vancomycin Hydrochloride 1g
Injections · Prescription medication
Aprogen Biosciences, Co., Ltd.
Vancomycin Hydrochloride 1g
Injections · Prescription medication
HK Innoen Co., Ltd.

Vancomycin Hydrochloride 250mg
Hard capsule · Prescription medication
Korea United Pharm., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.